Glimepiride / Metformin hydrochloride

Glimepiride/Metformin HCl is a fixed-dose oral antidiabetic combination used in the management of type 2 diabetes mellitus (T2DM). It combines:

• Glimepiride (a sulfonylurea insulin secretagogue)
• Metformin hydrochloride (a biguanide insulin sensitizer)

Mechanism of Action

This combination provides dual complementary glucose-lowering effects:

1. Glimepiride

• Stimulates insulin secretion from pancreatic β-cells
• Works by blocking ATP-sensitive potassium channels, leading to calcium influx and insulin release
• Effective only when some pancreatic insulin function is present

2. Metformin

• Reduces hepatic glucose production (gluconeogenesis)
• Improves peripheral insulin sensitivity (muscle and adipose tissue)
• Enhances glucose uptake and utilization

Combined Effect

• Addresses both:
  • Insulin deficiency (via glimepiride)
  • Insulin resistance (via metformin)
• Results in improved overall glycemic control

Indications

• Management of type 2 diabetes mellitus when:
  • Diet and exercise alone are insufficient
  • Monotherapy with either agent fails
• Helps reduce long-term complications such as:
  • Cardiovascular disease
  • Neuropathy
  • Nephropathy

Dosage (General Guidance)

• Individualized based on patient response
• Typically:
  • Glimepiride: 1–4 mg daily
  • Metformin: up to 2000 mg/day in divided doses

Common Side Effects

• Hypoglycemia (mainly due to glimepiride)
• Gastrointestinal disturbances:
  • Nausea, diarrhea, abdominal discomfort
• Headache, dizziness
• Rare:
  • Lactic acidosis (associated with metformin)
  • Hematologic or hypersensitivity reactions

Contraindications

• Type 1 diabetes mellitus
• Diabetic ketoacidosis
• Severe renal or hepatic impairment
• Metabolic acidosis or history of lactic acidosis
• Hypersensitivity to sulfonylureas or metformin

Warnings & Precautions

• Risk of hypoglycemia, especially with:
  • Irregular meals
  • Elderly patients
• Monitor:
  • Renal function (metformin accumulation risk)
  • Blood glucose regularly
• Use cautiously in:
  • Liver disease
  • Alcohol abuse
  • Severe illness or dehydration

Patient Disclaimer

This information is intended for educational purposes only and is based on reputable medical sources (.edu/.org). It does not replace professional medical advice, diagnosis, or treatment. Patients should not start, stop, or adjust this medication without consulting a qualified healthcare provider. Seek immediate medical attention if symptoms of severe hypoglycemia (such as confusion, fainting, or seizures) or lactic acidosis (such as unusual fatigue, muscle pain, or difficulty breathing) occur.